下肢静脉射频与激光消融术后深静脉血栓发生率及危险因素
基于Truven Health Marketscan 2007-16数据库,纳入256999例接受射频或激光消融的下肢静脉患者共433286次手术,30天内新发DVT为3.1%。激光消融较射频消融DVT风险低18%,女性及同日硬化剂治疗降低风险,外周动脉疾病及同期点式剥脱增加风险。
要点
- 消融术后30天内新发DVT发生率为3.1%,7天内为1.9%。
- 激光消融较射频消融30天DVT风险降低18%(OR 0.82)。
- 外周动脉疾病及同期点式剥脱与30天DVT风险升高相关。
核心结论
- 消融术后30天内新诊断DVT发生率为3.2%,近年风险下降,激光消融较射频消融风险降低18%。
研究设计与样本
- 回顾性数据库研究,查询Truven Health Marketscan 2007-16年数据,纳入接受RFA或LA且30天内行双功超声随访的患者,排除既往DVT诊断。
- 共256999例患者行433286次消融手术,其中RFA 192195次(44.4%),LA 241091次。
主要发现
- 8203次(1.9%)在术后7天内新诊断DVT,13347次(3.1%)在30天内新诊断DVT。
- 30天DVT发生率LA为2.8%,RFA为3.4%,P < 0.001。
- 多变量回归显示LA与30天DVT风险降低相关(OR 0.82;95%CI 0.80-0.85)。
- 女性(OR 0.74;95%CI 0.71-0.77)及同日行硬化剂治疗(OR 0.91;95%CI 0.85-0.98)与30天DVT风险降低相关。
- 外周动脉疾病(OR 1.23;95%CI 1.16-1.31)及同期点式剥脱(OR 1.43;95%CI 1.37-1.49)与30天DVT风险升高相关。
临床怎么用
- 消融术后应关注30天内DVT风险,尤其对合并外周动脉疾病或同期行点式剥脱的患者。
- 激光消融较射频消融DVT风险更低,女性及同日硬化剂治疗与风险降低相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The rates of thromboembolic complications such as deep vein thrombosis (DVT) after venous ablation procedures for symptomatic superficial venous insufficiency are controversial. We sought to describe the risk factors for and incidence of DVT after radiofrequency ablation (RFA) and laser ablation (LA). METHODS: We queried the Truven Health Marketscan Database from 2007-16 for patients who underwent RFA or LA and had a follow-up duplex ultrasound within 30 days of the ablation procedure. The primary outcome was DVT at 7 and 30 days identified by International Classification of Diseases-9 and International Classification of Diseases-10 codes. Multivariable regression was used to evaluate the patient and procedural variables associated with a DVT at 30 days, expressed as odds ratios (ORs) with a 95% confidence interval (95% CI). Patients and procedures with a previous DVT diagnosis were excluded. RESULTS: A total of 256,999 patients underwent 433,286 ablation procedures: 192,195 (44.4%) RFA and 241,091 LA. Of these, 8,203 (1.9%) had a newly diagnosed DVT within 7 days and 13,347 (3.1%) within 30 days of the procedure. The incidence of DVT decreased over the study period. LA (2.8%) demonstrated a lower incidence of DVT at 30 days compared with RFA (3.4%), P < 0.001. On multivariable regression, LA (OR, 0.82; 95% CI 0.80-0.85) was again associated with a decreased risk for 30-day DVT, as was female gender (OR, 0.74; 95% CI, 0.71-0.77), and sclerotherapy performed on the same day (OR, 0.91; 95% CI, 0.85-0.98). A diagnosis of peripheral artery disease (OR, 1.23; 95% CI, 1.16-1.31) and concomitant stab phlebectomy (OR, 1.43; 95% CI, 1.37-1.49) was associated with an increased risk of DVT within 30 days. CONCLUSIONS: The incidence of newly diagnosed DVT within 30 days of an ablation procedure was 3.2%. The risk for DVT decreased in recent years, and LA was associated with an 18% decreased risk compared with RFA.
引用
- Itoga NK, Rothenberg KA, Deslarzes-Dubuis C, et al. Incidence and Risk Factors for Deep Vein Thrombosis after Radiofrequency and Laser Ablation of the Lower Extremity Veins. Ann Vasc Surg. 2019. PMID: 31201974. doi:10.1016/j.avsg.2019.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。